Panthera is an independent SMO working with pharmaceutical and contract research organizations to find the right patient, for the right trial, at the right time through the recruitment and retention of patients at its own dedicated research sites.

Comprised of industry experts the Panthera team has come together to provide a professional, flexible and independent solution for clinical trials.

Dr Ian Smith, the founder of Synexus (the world’s largest SMO) is one of the founders of Panthera along with Professor John Lyon, previously a global executive in CRO Covance.

Jane Restorick has joined Panthera as Chief Operating Officer. Jane has extensive global experience in clinical trials and held the positions of COO and Chief Patient Officer at Synexus.

Panthera is aimed at recruiting patients for and running clinical trials in therapy areas which are traditionally managed in primary care including:

• Cardiac disease,

• Allergies,

• Migraine,

• Osteoarthritis,

• Osteoporosis,

• Diabetes etc.

Panthera intends to utilise innovative digital technologies to make clinical trials more accessible than ever for patients, customers and research staff and ensure that emerging technologies enabling the digitisation and virtualisation of trials is core to its strategy.

Panthera clinical trial sites have been designed to welcome patients and ensure they have a professional and superior experience. All sites offer accessibility, comfortable surroundings and dedicated time with doctors and nurses to ensure the patients fully engage in the studies and are fully compliant.

Sites are fitted with dedicated sample processing laboratories ensuring all trial processes are managed by fully qualified technical staff.

All the professional staff at all Panthera sites are GCP trained, and have considerable experience in the running of clinical trials and providing timely, accurate data.